๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Comparative Study of the First Dose Hypotensive Effects of Captopril and Perindopril in Patients with Heart Failure

โœ Scribed by Portuguese Community Hospital Study Group on Heart Failure,


Book ID
110323893
Publisher
Springer US
Year
2001
Tongue
English
Weight
155 KB
Volume
15
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A comparison of the effects of captopril
โœ A. J. Cowley; R. D. Wynne; A. Swami; J. Birkhead; A. Skene; J. R. Hampton ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 542 KB

Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot

A lack of effect of captopril on platele
โœ I. F. Gow; A. D. Flapan; M. Morris; E. Davies; B. C. Williams; P. L. Padfield; T ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 319 KB

We have studied the acute and chronic effects of an ACE inhibitor (captopril) on platelet function and the renin-angiotensin system in patients with congestive heart failure. Plasma concentrations of angiotensin II fell significantly after a single dose of captopril (25 mg) and during long-term trea

A pharmacokinetic and pharmacodynamic ev
โœ J. C. McElnay; T. A. Al-Furaih; C. M. Hughes; M. G. Scott; D. P. Nicholls ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer ๐ŸŒ English โš– 538 KB

Objective: The pharmacokinetics and pharmacodynamics of buffered sublingual captopril were assessed in patients with congestive heart failure (CHF). Methods: The study was carried out in a randomised single-blind cross-over fashion (n = 6, 4 males and 2 females) and involved two study days, at least

The central haemodynamic effects of a si
โœ H. Markus; A. J. Cowley ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 332 KB

The acute central haemodynamic and neuroendocrine effects of intravenous flosequinan were studied in a group of 10 patients with severe heart failure. Flosequinan improved cardiac output by a maximum of 1.59 l.min-1, it reduced pulmonary capillary wedge pressure by 11.9 mm Hg and it also caused a re